Intercontinental Wealth Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,725
Closed -$29K 433
2019
Q3
$29K Hold
5,725
0.02% 254
2019
Q2
$35K Buy
+5,725
New +$35K 0.02% 234